Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-04-19

FDA Approved: ACITRETIN — Supplemental Application (Sigmapharm Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for acitretin submitted by Sigmapharm Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acitretin (Acitretin)

Snippet

SUPPL AP for ACITRETIN (ACITRETIN)